No abstract available
Keywords:
COVID-19; SARS virus; coronavirus; myocarditis; severe acute respiratory syndrome coronavirus 2; transplant recipients.
MeSH terms
-
Acute Coronary Syndrome / diagnosis
-
Adult
-
COVID-19
-
Cardiac Catheterization
-
Cardiovascular Agents / therapeutic use
-
Cardiovascular Diseases / diagnosis
-
Cardiovascular Diseases / etiology*
-
Combined Modality Therapy
-
Coronavirus Infections / complications
-
Coronavirus Infections / diagnosis*
-
Coronavirus Infections / drug therapy
-
Diabetes Mellitus, Type 2 / complications
-
Diagnosis, Differential
-
Extracorporeal Membrane Oxygenation / methods
-
Female
-
Heart Failure / diagnosis
-
Heart Failure / drug therapy
-
Heart Failure / etiology*
-
Heart Failure / therapy
-
Heart Transplantation
-
Humans
-
Hyperlipidemias / complications
-
Hypertension / complications
-
Hypertrophy, Left Ventricular / complications
-
Immunosuppressive Agents / adverse effects
-
Intra-Aortic Balloon Pumping
-
Kidney Transplantation
-
Male
-
Middle Aged
-
Pandemics
-
Pericarditis / diagnosis
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / diagnosis*
-
Pneumonia, Viral / drug therapy
-
Postoperative Complications / diagnosis
-
Postoperative Complications / etiology
-
Respiration, Artificial
-
Respiratory Distress Syndrome / etiology
-
Respiratory Distress Syndrome / therapy
-
Shock, Cardiogenic / diagnosis
-
Shock, Cardiogenic / etiology*
-
Shock, Cardiogenic / therapy
Substances
-
Cardiovascular Agents
-
Immunosuppressive Agents